Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Tempo Scan Pacific TbkPEXXF 96 3-Year EBITDA Growth Rate is 9.60% as of Jun. 2026, which is 25% below its 10-year median of 12.75. GuruFocus rates PEXXF with a GF Scoreâ„¢ of 96/100 and a GF Valueâ„¢ of $0.08. The stock has 2 warning signs investors should review. Among 474 Conglomerates companies, PT Tempo Scan Pacific Tbk ranks better than 53.8% on this metric.
During the past 12 months, PT Tempo Scan Pacific Tbk's average EBITDA Per Share Growth Rate was 6.80% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 9.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 12.70% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 11.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of PT Tempo Scan Pacific Tbk was 27.30% per year. The lowest was -2.50% per year. And the median was 12.75% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
PT Tempo Scan Pacific Tbk 3-Year EBITDA Growth Rate Related Terms
PEXXF vs MMM, HON: 3-Year EBITDA Growth Rate Comparison
For the Conglomerates subindustry, PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Tempo Scan Pacific Tbk 3-Year EBITDA Growth Rate vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate falls into.
PT Tempo Scan Pacific Tbk 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 9.60% mean?
PT Tempo Scan Pacific Tbk (PEXXF) has a 3-Year EBITDA Growth Rate of 9.60% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for PT Tempo Scan Pacific Tbk and its competitors. This is 25% below median its historical median of 12.75. According to the industry distribution chart, PT Tempo Scan Pacific Tbk ranks #219 out of 474 companies in the Conglomerates industry, placing it in the top 46.2%.
Is PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate too high?
PT Tempo Scan Pacific Tbk's current 3-Year EBITDA Growth Rate of 9.60% is 25% below median its 10-year median of 12.75. The Conglomerates industry median 3-Year EBITDA Growth Rate is 7.40. PT Tempo Scan Pacific Tbk's value of 9.60% is 29.7% above this industry median. Based on the distribution chart, PT Tempo Scan Pacific Tbk ranks #219 out of 474 companies in the Conglomerates industry, which is above the industry midpoint. Overall, PT Tempo Scan Pacific Tbk has a GF Scoreâ„¢ of 96/100, reflecting its overall financial health beyond just this single metric.
How does PT Tempo Scan Pacific Tbk's 3-Year EBITDA Growth Rate compare to MMM and HON?
According to the Conglomerates industry distribution chart, PT Tempo Scan Pacific Tbk ranks #219 out of 474 companies for 3-Year EBITDA Growth Rate. This puts PT Tempo Scan Pacific Tbk in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 7.40. PT Tempo Scan Pacific Tbk's value of 9.60% is 29.7% above this benchmark. While the company's 10-year median is 12.75 vs. the industry median of 7.40, PT Tempo Scan Pacific Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Conglomerates company?
The median 3-Year EBITDA Growth Rate among Conglomerates companies is 7.40, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Tempo Scan Pacific Tbk's current 3-Year EBITDA Growth Rate of 9.60% is 29.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for PT Tempo Scan Pacific Tbk and its competitors. For the Conglomerates industry, the median 3-Year EBITDA Growth Rate is 7.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Tempo Scan Pacific Tbk's current 3-Year EBITDA Growth Rate is 9.60%, which is 25% below median its own 10-year median of 12.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Tempo Scan Pacific Tbk stock overvalued right now?
PT Tempo Scan Pacific Tbk (PEXXF) has a current 3-Year EBITDA Growth Rate of 9.60%. The stock's GF Value™ is $0.08, compared to a current price of $0.09 — trading 12.5% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 9.60%, which is 25% below median its 10-year median of 12.75 and 29.7% above the Conglomerates industry median of 7.40. PT Tempo Scan Pacific Tbk's overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For PT Tempo Scan Pacific Tbk (PEXXF), the current 3-Year EBITDA Growth Rate is 9.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Tempo Scan Pacific Tbk (PEXXF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Tempo Scan Pacific Tbk stock appears to be overvalued.
The current stock price of $0.09 is trading 12.5% above its estimated GF Value™ of $0.08.
Key valuation signals for PEXXF:
3-Year EBITDA Growth Rate: 9.60% (25% below median its 10-year median of 12.75)
GF Value™: $0.08 vs. price of $0.09 (12.5% above fair value)
Industry Position: 29.7% above the Conglomerates median (#219 of 474)
No single metric tells the full story. See the PEXXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Tempo Scan Pacific Tbk operates in the pharmaceutical business in Indonesia. It is engaged in the production of tablet/caplets, effervescent powders, liquid/syrup, cream and ointment, and capsule dosage forms, and markets body care products. It operates through the following segments: The Pharmaceuticals segment, the Consumer Products and Cosmetics segment, and the Distribution Services segment. The company caters to both Indonesian and international markets.
96GF Score
Get the complete analysis for PEXXF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PEXXF has been successfully added to your 
